Finance News

DexCom shares tumble nearly 40% after company cuts sales forecast




DexCom Inc., a maker of monitoring devices for diabetes patients, cut its full-year sales outlook on Thursday — a move that surprised some analysts and investors and sent its stock tumbling after hours — as the company deals with a shortfall in new patients and weaker trends abroad.



Read More: DexCom shares tumble nearly 40% after company cuts sales forecast

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More